PERCEPTIVE ADVISORS LLC Insider Trading
Get the latest insider transactions of PERCEPTIVE ADVISORS LLC. PERCEPTIVE ADVISORS LLC is 10% Owner in LA JOLLA PHARMACEUTICAL CO ($LJPC) and 10% Owner in VBI VACCINES INC. ($VBIV) and in AMICUS THERAPEUTICS INC ($FOLD) and 10% Owner in AMICUS THERAPEUTICS INC ($FOLD) and 10% Owner in SCYNEXIS INC ($SCYX) and in AGILE THERAPEUTICS INC ($AGRX) and 10% Owner in AGILE THERAPEUTICS INC ($AGRX) and 10% Owner in Athenex, Inc. ($ATNX) and 10% Owner in ALBIREO PHARMA, INC. ($ALBO) and Director in Lyra Therapeutics, Inc. ($LYRA) and 10% Owner in VBI Vaccines Inc/BC ($VBIV) and 10% Owner in Aldeyra Therapeutics, Inc. ($ALDX) and 10% Owner in ADMA BIOLOGICS, INC. ($ADMA) and 10% Owner in ZOGENIX, INC. ($ZGNX) and 10% Owner in ACELRX PHARMACEUTICALS INC ($ACRX) and Director in CATABASIS PHARMACEUTICALS INC ($CATB) and 10% Owner in LEAP THERAPEUTICS, INC. ($LPTX) and 10% Owner in Versartis, Inc. ($VSAR) and in Kadmon Holdings, Inc. ($KDMN) and 10% Owner in Menlo Therapeutics Inc. ($MNLO) and 10% Owner in Corium International, Inc. ($CORI) and 10% Owner in Quotient Ltd ($QTNT) and 10% Owner in Athira Pharma, Inc. ($ATHA) and Director in Athira Pharma, Inc. ($ATHA) and 10% Owner in Global Blood Therapeutics, Inc. ($GBT) and 10% Owner in Verrica Pharmaceuticals Inc. ($VRCA) and 10% Owner in Crinetics Pharmaceuticals, Inc. ($CRNX) and Director in Crinetics Pharmaceuticals, Inc. ($CRNX) and 10% Owner in Dova Pharmaceuticals, Inc. ($DOVA) and 10% Owner in Motus GI Holdings, Inc. ($MOTS) and 10% Owner in Prometheus Biosciences, Inc. ($RXDX) and 10% Owner in Rain Therapeutics Inc. ($RAIN) and Director in Solid Biosciences Inc. ($SLDB) and Director in MeiraGTx Holdings plc ($MGTX) and Director in Landos Biopharma, Inc. ($LABP) and Director in ARYA Sciences Acquisition Corp II ($ARYB). Discover the current value of PERCEPTIVE ADVISORS LLC shares.
Address: PERCEPTIVE CAPITAL 5437 CONNECTICUT AVENUE NW STE 100 WASHINGTON 20015DC
PERCEPTIVE ADVISORS LLC is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
VBIV | VBI VACCINES INC. | 10% Owner | 6,213,314 | 25,412,454.26 |
ACRX | ACELRX PHARMACEUTICALS INC | 10% Owner | 4,533,728 | 13,601,184.00 |
FOLD | AMICUS THERAPEUTICS, INC. | 10% Owner | 20,694,424 | 124,580,432.48 |
ALDX | Aldeyra Therapeutics, Inc. | 10% Owner | 8,703,879 | 43,519,395.00 |
ARAV | Aravive, Inc. | 10% Owner | 4,102,984 | 54,569,687.20 |
CORI | Corium International, Inc. | 10% Owner | 6,074,686 | 17,191,361.38 |
ZGNX | ZOGENIX, INC. | 10% Owner | 4,070,357 | 34,598,034.50 |
VBIV | VBI Vaccines Inc/BC | 10% Owner | 55,042,456 | |
GBT | Global Blood Therapeutics, Inc. | 10% Owner | 4,889,066 | 79,202,869.20 |
ALBO | ALBIREO PHARMA, INC. | 10% Owner | 2,360,139 | 1,534,090.35 |
SLDB | Solid Biosciences Inc. | Director | 13,412,552 | |
LJPC | LA JOLLA PHARMACEUTICAL CO | 10% Owner | 3,881,967 | 75,581,897.49 |
MOTS | Motus GI Holdings, Inc. | 10% Owner | 3,884,894 | |
QTNT | Quotient Ltd | 10% Owner | 16,200,818 | 107,735,439.70 |
DOVA | Dova Pharmaceuticals Inc. | 10% Owner | 0 | |
MGTX | MeiraGTx Holdings plc | Director | 6,433,277 | |
CRNX | Crinetics Pharmaceuticals, Inc. | 10% Owner, Director | 3,659,381 | |
AGRX | AGILE THERAPEUTICS INC | 10% Owner | 15,919,925 | 37,730,222.25 |
VRCA | Verrica Pharmaceuticals Inc. | 10% Owner | 1,130,679 | |
MNLO | VYNE Therapeutics Inc. | 10% Owner | 5,773,954 | |
ATNX | Athenex, Inc. | 10% Owner | 11,732,467 | |
ADMA | ADMA BIOLOGICS, INC. | 10% Owner | 16,584,802 | 82,924,010.00 |
KDMN | Kadmon Holdings, Inc. | 14,636,334 | 58,398,972.66 | |
LYRA | Lyra Therapeutics, Inc. | Director | 1,934,115 | |
LPTX | LEAP THERAPEUTICS, INC. | 10% Owner | 8,476,496 | 61,369,831.04 |
ATHA | Athira Pharma, Inc. | Director, 10% Owner | 3,425,916 | |
CERE | Cerevel Therapeutics Holdings, Inc. | Director | 114,100 | |
SCYX | SCYNEXIS INC | 10% Owner | 2,215,000 | 6,977,250.00 |
CATB | CATABASIS PHARMACEUTICALS INC | Director | 0 | 0.00 |
LABP | Landos Biopharma, Inc. | Director | 7,077,017 | |
RXDX | Prometheus Biosciences, Inc. | 10% Owner | 1,017,770 | |
RAIN | Rain Therapeutics Inc. | 10% Owner | 879,703 |
Insider Trading Transactions of PERCEPTIVE ADVISORS LLC
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
Jun 01 2021 | ATHA | Athira Pharma, Inc. | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | 19.94 | 13,871 | 276,588 | 13,871 |
May 07 2021 | MNLO | VYNE Therapeutics Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | 3.67 | 1,000,000 | 3,670,000 | 5,773,954 |
Apr 27 2021 | RAIN | Rain Therapeutics Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 0.00 | 879,703 | 0 | 879,703 |
Apr 27 2021 | RAIN | Rain Therapeutics Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 0.00 | 1,107,316 | 0 | 1,987,019 |
Apr 27 2021 | RAIN | Rain Therapeutics Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 17.00 | 550,000 | 9,350,000 | 2,537,019 |
Apr 27 2021 | RAIN | Rain Therapeutics Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | 0.00 | 949,992 | 0 | 0 |
Apr 27 2021 | RAIN | Rain Therapeutics Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | 0.00 | 1,195,792 | 0 | 0 |
Apr 06 2021 | AGRX | AGILE THERAPEUTICS INC | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | 2.87 | 450,000 | 1,291,500 | 450,000 |
Mar 23 2021 | SLDB | Solid Biosciences Inc. | PERCEPTIVE ADVISORS LLC | Director | Buy | 5.75 | 2,608,695 | 14,999,996 | 13,412,552 |
Mar 16 2021 | RXDX | Prometheus Biosciences, I ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 0.00 | 1,017,770 | 0 | 1,017,770 |
Mar 16 2021 | RXDX | Prometheus Biosciences, I ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 0.00 | 1,446,262 | 0 | 2,464,032 |
Mar 16 2021 | RXDX | Prometheus Biosciences, I ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 19.00 | 850,000 | 16,150,000 | 3,314,032 |
Mar 16 2021 | RXDX | Prometheus Biosciences, I ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | 0.00 | 10,177,703 | 0 | 0 |
Mar 16 2021 | RXDX | Prometheus Biosciences, I ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | 0.00 | 14,462,623 | 0 | 0 |
Feb 09 2021 | LABP | Landos Biopharma, Inc. | PERCEPTIVE ADVISORS LLC | Director | Buy | 11.14 | 27,453 | 305,826 | 7,077,017 |
Feb 09 2021 | LABP | Landos Biopharma, Inc. | PERCEPTIVE ADVISORS LLC | Director | Buy | 11.38 | 34,611 | 393,873 | 7,111,628 |
Feb 09 2021 | LABP | Landos Biopharma, Inc. | PERCEPTIVE ADVISORS LLC | Director | Buy | 12.53 | 86,671 | 1,085,988 | 7,198,299 |
Feb 09 2021 | LABP | Landos Biopharma, Inc. | PERCEPTIVE ADVISORS LLC | Director | Buy | 13.10 | 1,771 | 23,200 | 7,200,070 |
Feb 09 2021 | LABP | Landos Biopharma, Inc. | PERCEPTIVE ADVISORS LLC | Director | Buy | 13.80 | 64,730 | 893,274 | 7,264,800 |
Feb 09 2021 | LABP | Landos Biopharma, Inc. | PERCEPTIVE ADVISORS LLC | Director | Buy | 14.60 | 34,951 | 510,285 | 7,299,751 |
Feb 08 2021 | LABP | Landos Biopharma, Inc. | PERCEPTIVE ADVISORS LLC | Director | Buy | 0.00 | 2,941,769 | 0 | 2,941,769 |
Feb 08 2021 | LABP | Landos Biopharma, Inc. | PERCEPTIVE ADVISORS LLC | Director | Buy | 0.00 | 2,941,769 | 0 | 2,941,769 |
Feb 08 2021 | LABP | Landos Biopharma, Inc. | PERCEPTIVE ADVISORS LLC | Director | Buy | 0.00 | 2,857,795 | 0 | 5,799,564 |
Feb 08 2021 | LABP | Landos Biopharma, Inc. | PERCEPTIVE ADVISORS LLC | Director | Buy | 0.00 | 2,857,795 | 0 | 5,799,564 |
Feb 08 2021 | LABP | Landos Biopharma, Inc. | PERCEPTIVE ADVISORS LLC | Director | Buy | 0.00 | 1,770,600 | 0 | 1,770,600 |
Feb 08 2021 | LABP | Landos Biopharma, Inc. | PERCEPTIVE ADVISORS LLC | Director | Buy | 16.00 | 1,250,000 | 20,000,000 | 7,049,564 |
Feb 08 2021 | LABP | Landos Biopharma, Inc. | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | 0.00 | 2,941,769 | 0 | 0 |
Feb 08 2021 | LABP | Landos Biopharma, Inc. | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | 0.00 | 2,941,769 | 0 | 0 |
Feb 08 2021 | LABP | Landos Biopharma, Inc. | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | 0.00 | 2,857,795 | 0 | 0 |
Feb 08 2021 | LABP | Landos Biopharma, Inc. | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | 0.00 | 2,857,795 | 0 | 0 |
Feb 08 2021 | LABP | Landos Biopharma, Inc. | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | 0.00 | 1,770,600 | 0 | 0 |
Feb 03 2021 | CATB | CATABASIS PHARMACEUTICALS ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | 0.00 | 4,851 | 0 | 4,851 |
Feb 03 2021 | CATB | CATABASIS PHARMACEUTICALS ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | 0.00 | 1,617 | 0 | 30,920 |
Feb 01 2021 | MNLO | VYNE Therapeutics Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 2.37 | 4,219,409 | 9,999,999 | 27,095,819 |
Jan 27 2021 | ATHA | Athira Pharma, Inc. | PERCEPTIVE ADVISORS LLC | Director | Buy | 22.50 | 311,111 | 6,999,998 | 3,425,916 |
Jan 26 2021 | SCYX | SCYNEXIS INC | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | 7.43 | 185,000 | 1,374,550 | 2,215,000 |
Jan 26 2021 | SCYX | SCYNEXIS INC | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | 7.38 | 95,000 | 701,100 | 2,120,000 |
Jan 26 2021 | SCYX | SCYNEXIS INC | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | 8.16 | 285,151 | 2,326,832 | 1,833,849 |
Jan 26 2021 | SCYX | SCYNEXIS INC | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | 8.95 | 33,849 | 302,949 | 1,800,000 |
Jan 22 2021 | MOTS | Motus GI Holdings, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | 1.80 | 325,648 | 586,166 | 3,884,894 |
Jan 22 2021 | MOTS | Motus GI Holdings, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | 1.68 | 674,352 | 1,132,911 | 3,210,542 |
Jan 22 2021 | MOTS | Motus GI Holdings, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | 1.48 | 550,000 | 814,000 | 2,660,542 |
Jan 22 2021 | MOTS | Motus GI Holdings, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | 1.80 | 325,648 | 586,166 | 3,884,894 |
Jan 22 2021 | MOTS | Motus GI Holdings, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | 1.68 | 674,352 | 1,132,911 | 3,210,542 |
Jan 22 2021 | MOTS | Motus GI Holdings, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | 1.48 | 550,000 | 814,000 | 2,660,542 |
Jan 21 2021 | ALDX | Aldeyra Therapeutics, Inc ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 9.50 | 1,368,421 | 13,000,000 | 8,703,879 |
Jan 11 2021 | ALDX | Aldeyra Therapeutics, Inc ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 8.13 | 500,000 | 4,065,000 | 6,785,458 |
Jan 11 2021 | ALDX | Aldeyra Therapeutics, Inc ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 9.21 | 347,332 | 3,198,928 | 7,132,790 |
Jan 11 2021 | ALDX | Aldeyra Therapeutics, Inc ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 10.21 | 152,668 | 1,558,740 | 7,285,458 |
Jan 11 2021 | ALDX | Aldeyra Therapeutics, Inc ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 7.60 | 50,000 | 380,000 | 7,335,458 |
Jan 11 2021 | ALDX | Aldeyra Therapeutics, Inc ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 8.13 | 500,000 | 4,065,000 | 6,785,458 |
Jan 11 2021 | ALDX | Aldeyra Therapeutics, Inc ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 9.21 | 347,332 | 3,198,928 | 7,132,790 |
Jan 11 2021 | ALDX | Aldeyra Therapeutics, Inc ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 10.21 | 152,668 | 1,558,740 | 7,285,458 |
Jan 11 2021 | ALDX | Aldeyra Therapeutics, Inc ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 7.60 | 50,000 | 380,000 | 7,335,458 |
Dec 15 2020 | SLDB | Solid Biosciences Inc. | PERCEPTIVE ADVISORS LLC | Director | Buy | 3.70 | 4,054,054 | 15,000,000 | 10,803,857 |
Oct 22 2020 | ARYB | ARYA Sciences Acquisition ... | PERCEPTIVE ADVISORS LLC | Director | Buy | 10.00 | 114,100 | 1,141,000 | 114,100 |
Oct 22 2020 | ARYB | ARYA Sciences Acquisition ... | PERCEPTIVE ADVISORS LLC | Director | Buy | 10.00 | 114,100 | 1,141,000 | 114,100 |
Oct 22 2020 | ARYB | ARYA Sciences Acquisition ... | PERCEPTIVE ADVISORS LLC | Director | Buy | 10.09 | 43,195 | 435,838 | 157,295 |
Oct 22 2020 | ARYB | ARYA Sciences Acquisition ... | PERCEPTIVE ADVISORS LLC | Director | Buy | 10.09 | 43,195 | 435,838 | 157,295 |
Sep 22 2020 | ATHA | Athira Pharma, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 0.00 | 1,644,785 | 0 | 2,055,981 |
Sep 22 2020 | ATHA | Athira Pharma, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 17.00 | 1,058,824 | 18,000,008 | 3,114,805 |
Sep 22 2020 | ATHA | Athira Pharma, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | 0.00 | 1,644,785 | 0 | 0 |
Sep 16 2020 | QTNT | Quotient Ltd | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 4.25 | 2,911,764 | 12,374,997 | 16,200,818 |
Sep 15 2020 | ALBO | ALBIREO PHARMA, INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 40.00 | 400,000 | 16,000,000 | 2,360,139 |
Sep 14 2020 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 11.24 | 200,000 | 2,248,000 | 11,732,467 |
Sep 14 2020 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 11.00 | 1,800,000 | 19,800,000 | 13,532,467 |
Jul 13 2020 | ALDX | Aldeyra Therapeutics, Inc ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 4.25 | 3,200,000 | 13,600,000 | 6,285,458 |
Jun 24 2020 | LPTX | LEAP THERAPEUTICS, INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 2.00 | 1,750,000 | 3,500,000 | 8,476,496 |
Jun 18 2020 | SLDB | Solid Biosciences Inc. | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | 3.03 | 30,000 | 90,900 | 30,000 |
Jun 11 2020 | MNLO | Menlo Therapeutics Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 1.85 | 2,702,702 | 4,999,999 | 22,876,410 |
Jun 04 2020 | MGTX | MeiraGTx Holdings plc | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | 13.85 | 25,000 | 346,250 | 25,000 |
Jun 04 2020 | MGTX | MeiraGTx Holdings plc | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | 13.85 | 25,000 | 346,250 | 25,000 |
May 29 2020 | LYRA | Lyra Therapeutics, Inc. | PERCEPTIVE ADVISORS LLC | Director | Buy | 16.00 | 625,000 | 10,000,000 | 1,934,115 |
May 06 2020 | LYRA | Lyra Therapeutics, Inc. | PERCEPTIVE ADVISORS LLC | Director | Buy | 0.00 | 773,327 | 0 | 773,327 |
May 06 2020 | LYRA | Lyra Therapeutics, Inc. | PERCEPTIVE ADVISORS LLC | Director | Buy | 0.00 | 1,132,016 | 0 | 1,132,016 |
May 06 2020 | LYRA | Lyra Therapeutics, Inc. | PERCEPTIVE ADVISORS LLC | Director | Buy | 0.00 | 470,739 | 0 | 1,244,066 |
May 06 2020 | LYRA | Lyra Therapeutics, Inc. | PERCEPTIVE ADVISORS LLC | Director | Buy | 8.63 | 141,221 | 1,218,737 | 1,385,287 |
May 06 2020 | LYRA | Lyra Therapeutics, Inc. | PERCEPTIVE ADVISORS LLC | Director | Sell | 16.00 | 76,172 | 1,218,752 | 1,309,115 |
May 06 2020 | LYRA | Lyra Therapeutics, Inc. | PERCEPTIVE ADVISORS LLC | Director | Buy | 8.63 | 339,604 | 2,930,783 | 1,471,620 |
May 06 2020 | LYRA | Lyra Therapeutics, Inc. | PERCEPTIVE ADVISORS LLC | Director | Sell | 16.00 | 183,174 | 2,930,784 | 1,288,446 |
May 06 2020 | LYRA | Lyra Therapeutics, Inc. | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | 0.00 | 26,666,666 | 0 | 0 |
May 06 2020 | LYRA | Lyra Therapeutics, Inc. | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | 0.00 | 39,035,325 | 0 | 0 |
May 06 2020 | LYRA | Lyra Therapeutics, Inc. | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | 0.00 | 16,232,511 | 0 | 0 |
May 06 2020 | LYRA | Lyra Therapeutics, Inc. | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | 8.63 | 141,221 | 1,218,737 | 0 |
May 06 2020 | LYRA | Lyra Therapeutics, Inc. | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | 8.63 | 339,604 | 2,930,783 | 0 |
May 01 2020 | LYRA | Lyra Therapeutics, Inc. | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | 16.00 | 14,500 | 232,000 | 14,500 |
May 01 2020 | LYRA | Lyra Therapeutics, Inc. | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | 16.00 | 14,500 | 232,000 | 14,500 |
May 01 2020 | LYRA | Lyra Therapeutics, Inc. | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | 16.00 | 14,500 | 232,000 | 14,500 |
May 01 2020 | LYRA | Lyra Therapeutics, Inc. | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | 16.00 | 14,500 | 232,000 | 14,500 |
Apr 28 2020 | VBIV | VBI Vaccines Inc/BC | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 1.10 | 9,090,909 | 10,000,000 | 55,042,456 |
Apr 20 2020 | CRNX | Crinetics Pharmaceuticals ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 14.00 | 1,071,428 | 14,999,992 | 3,659,381 |
Mar 23 2020 | ADMA | ADMA BIOLOGICS, INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 2.10 | 500,000 | 1,050,000 | 16,584,802 |
Mar 17 2020 | AGRX | AGILE THERAPEUTICS INC | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 1.75 | 1,000,000 | 1,750,000 | 15,919,925 |
Feb 25 2020 | AGRX | AGILE THERAPEUTICS INC | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 3.00 | 3,000,000 | 9,000,000 | 14,919,925 |
Feb 25 2020 | AGRX | AGILE THERAPEUTICS INC | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | 3.74 | 700,000 | 2,618,000 | 700,000 |
Feb 25 2020 | AGRX | AGILE THERAPEUTICS INC | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | 4.67 | 700,000 | 3,269,000 | 700,000 |
Feb 11 2020 | ADMA | ADMA BIOLOGICS, INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 3.50 | 4,563,700 | 15,972,950 | 16,084,802 |
Feb 04 2020 | ALBO | ALBIREO PHARMA, INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 21.00 | 255,809 | 5,371,989 | 1,960,139 |
Dec 27 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 14.39 | 73,698 | 1,060,514 | 11,532,467 |
Dec 26 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 13.72 | 142,812 | 1,959,381 | 10,995,279 |
Dec 26 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 13.86 | 120,931 | 1,676,104 | 11,116,210 |
Dec 26 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 14.14 | 189,322 | 2,677,013 | 11,305,532 |
Dec 26 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 14.30 | 153,237 | 2,191,289 | 11,458,769 |
Nov 18 2019 | KDMN | Kadmon Holdings, Inc. | PERCEPTIVE ADVISORS LLC | Buy | 3.40 | 1,470,588 | 4,999,999 | 14,636,334 | |
Nov 18 2019 | AGRX | AGILE THERAPEUTICS INC | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 1.69 | 435,015 | 735,175 | 6,586,125 |
Nov 18 2019 | AGRX | AGILE THERAPEUTICS INC | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 1.72 | 3,000,000 | 5,160,000 | 9,586,125 |
Nov 18 2019 | AGRX | AGILE THERAPEUTICS INC | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 1.60 | 2,000,000 | 3,200,000 | 11,586,125 |
Nov 18 2019 | AGRX | AGILE THERAPEUTICS INC | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 1.74 | 333,800 | 580,812 | 11,919,925 |
Nov 15 2019 | DOVA | Dova Pharmaceuticals Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | 0.00 | 3,125,851 | 0 | 0 |
Nov 15 2019 | DOVA | Dova Pharmaceuticals Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | 0.00 | 3,125,851 | 0 | 0 |
Nov 12 2019 | QTNT | Quotient Ltd | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 7.00 | 2,500,000 | 17,500,000 | 13,289,054 |
Oct 31 2019 | AGRX | AGILE THERAPEUTICS INC | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | 0.44 | 760,291 | 334,528 | 6,151,110 |
Oct 30 2019 | AGRX | AGILE THERAPEUTICS INC | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 0.95 | 2,300,000 | 2,185,000 | 10,726,750 |
Oct 30 2019 | AGRX | AGILE THERAPEUTICS INC | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | 0.51 | 3,815,349 | 1,945,828 | 6,911,401 |
Oct 21 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 10.93 | 50,000 | 546,500 | 10,852,467 |
Oct 18 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 10.29 | 67,222 | 691,714 | 10,802,467 |
Sep 24 2019 | VBIV | VBI Vaccines Inc/BC | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 0.50 | 20,000,000 | 10,000,000 | 45,951,556 |
Sep 18 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 13.58 | 30,000 | 407,400 | 10,735,245 |
Sep 16 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 14.05 | 13,584 | 190,855 | 10,648,829 |
Sep 16 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 14.27 | 56,416 | 805,056 | 10,705,245 |
Aug 20 2019 | MGTX | MeiraGTx Holdings plc | PERCEPTIVE ADVISORS LLC | Director | Buy | 23.50 | 425,531 | 9,999,979 | 6,433,277 |
Aug 16 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 15.00 | 30,000 | 450,000 | 10,615,245 |
Aug 16 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 14.96 | 20,000 | 299,200 | 10,635,245 |
Aug 09 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 17.85 | 23,073 | 411,853 | 9,799,837 |
Aug 09 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 17.90 | 20,786 | 372,069 | 9,820,623 |
Aug 09 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 17.89 | 1,495 | 26,746 | 9,822,118 |
Aug 09 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 13.12 | 74,855 | 982,098 | 9,896,973 |
Aug 09 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 14.14 | 371,756 | 5,256,630 | 10,268,729 |
Aug 09 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 15.04 | 248,752 | 3,741,230 | 10,517,481 |
Aug 09 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 15.79 | 37,764 | 596,294 | 10,555,245 |
Aug 09 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 15.76 | 30,000 | 472,800 | 10,585,245 |
Jul 29 2019 | SLDB | Solid Biosciences Inc. | PERCEPTIVE ADVISORS LLC | Director | Buy | 4.65 | 2,822,581 | 13,125,002 | 6,749,803 |
Jul 11 2019 | DOVA | Dova Pharmaceuticals Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 16.61 | 29,834 | 495,543 | 3,653,435 |
Jul 11 2019 | DOVA | Dova Pharmaceuticals Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 16.89 | 12,354 | 208,659 | 3,665,789 |
Jul 11 2019 | DOVA | Dova Pharmaceuticals Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 16.61 | 29,834 | 495,543 | 3,653,435 |
Jul 11 2019 | DOVA | Dova Pharmaceuticals Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 16.67 | 42,916 | 715,410 | 3,708,705 |
Jul 11 2019 | DOVA | Dova Pharmaceuticals Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 16.89 | 12,354 | 208,659 | 3,665,789 |
Jul 11 2019 | DOVA | Dova Pharmaceuticals Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 16.67 | 42,916 | 715,410 | 3,708,705 |
Jul 09 2019 | DOVA | Dova Pharmaceuticals Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 16.46 | 50,000 | 823,000 | 3,632,601 |
Jul 03 2019 | DOVA | Dova Pharmaceuticals Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 14.24 | 18,121 | 258,043 | 3,571,181 |
Jul 03 2019 | DOVA | Dova Pharmaceuticals Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 16.14 | 715 | 11,540 | 3,571,896 |
Jul 03 2019 | DOVA | Dova Pharmaceuticals Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 16.67 | 1,705 | 28,422 | 3,573,601 |
Jul 01 2019 | MOTS | Motus GI Holdings, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 3.00 | 1,000,000 | 3,000,000 | 4,210,542 |
Jul 01 2019 | DOVA | Dova Pharmaceuticals Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 12.46 | 140,513 | 1,750,792 | 3,266,364 |
Jul 01 2019 | DOVA | Dova Pharmaceuticals Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 13.58 | 186,696 | 2,535,332 | 3,453,060 |
Jul 01 2019 | DOVA | Dova Pharmaceuticals Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 13.97 | 60,617 | 846,819 | 3,513,560 |
Jul 01 2019 | DOVA | Dova Pharmaceuticals Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 14.48 | 39,383 | 570,266 | 3,553,060 |
Jun 21 2019 | MGTX | MeiraGTx Holdings plc | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | 21.28 | 25,000 | 532,000 | 25,000 |
Jun 20 2019 | VBIV | VBI Vaccines Inc/BC | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 0.65 | 1,000,000 | 650,000 | 25,951,556 |
Jun 20 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 17.73 | 50,742 | 899,656 | 9,776,764 |
Jun 19 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 17.94 | 130,000 | 2,332,200 | 9,726,022 |
Jun 18 2019 | VBIV | VBI Vaccines Inc/BC | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 0.62 | 1,000,000 | 618,000 | 24,951,556 |
Jun 18 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 17.69 | 324,290 | 5,736,690 | 9,596,022 |
Jun 17 2019 | SLDB | Solid Biosciences Inc. | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | 5.26 | 10,000 | 52,600 | 10,000 |
Jun 17 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 17.05 | 75,710 | 1,290,856 | 9,271,732 |
May 23 2019 | ADMA | ADMA BIOLOGICS, INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 4.00 | 4,000,000 | 16,000,000 | 11,521,102 |
May 23 2019 | ADMA | ADMA BIOLOGICS, INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | 3.28 | 1,360,000 | 4,457,400 | 1,360,000 |
May 23 2019 | ADMA | ADMA BIOLOGICS, INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | 4.64 | 250,000 | 1,160,000 | 250,000 |
May 08 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 12.08 | 22,990 | 277,719 | 9,119,012 |
May 08 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 12.90 | 77,010 | 993,429 | 9,196,022 |
Jan 17 2019 | MOTS | Motus GI Holdings, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 5.00 | 10,000 | 50,000 | 2,810,541 |
Jan 17 2019 | MOTS | Motus GI Holdings, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 2.70 | 400,000 | 1,080,000 | 3,210,541 |
Jan 09 2019 | LJPC | LA JOLLA PHARMACEUTICAL C ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | 5.64 | 431,644 | 2,434,472 | 3,881,967 |
Jan 09 2019 | LJPC | LA JOLLA PHARMACEUTICAL C ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | 6.67 | 147,497 | 983,805 | 3,734,470 |
Jan 09 2019 | LJPC | LA JOLLA PHARMACEUTICAL C ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | 7.56 | 131,866 | 996,907 | 3,602,604 |
Jan 09 2019 | LJPC | LA JOLLA PHARMACEUTICAL C ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | 9.05 | 34,401 | 311,329 | 3,568,203 |
Jan 09 2019 | LJPC | LA JOLLA PHARMACEUTICAL C ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | 9.52 | 4,592 | 43,716 | 3,563,611 |
Jan 09 2019 | LJPC | LA JOLLA PHARMACEUTICAL C ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | 5.26 | 4,200 | 22,092 | 3,559,411 |
Jan 09 2019 | LJPC | LA JOLLA PHARMACEUTICAL C ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | 6.46 | 25,800 | 166,668 | 3,533,611 |
Jan 09 2019 | LJPC | LA JOLLA PHARMACEUTICAL C ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | 5.26 | 4,200 | 22,092 | 3,529,411 |
Jan 09 2019 | LJPC | LA JOLLA PHARMACEUTICAL C ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | 6.46 | 25,800 | 166,668 | 3,503,611 |
Jan 09 2019 | LJPC | LA JOLLA PHARMACEUTICAL C ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | 5.25 | 800,000 | 4,200,000 | 2,703,611 |
Jan 09 2019 | LJPC | LA JOLLA PHARMACEUTICAL C ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | 5.26 | 450,235 | 2,368,236 | 2,253,376 |
Dec 17 2018 | VBIV | VBI Vaccines Inc/BC | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 1.40 | 14,285,714 | 20,000,000 | 23,631,439 |
Dec 10 2018 | QTNT | Quotient Ltd | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 6.50 | 2,000,000 | 13,000,000 | 10,789,054 |
Oct 15 2018 | CORI | Corium International, Inc ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | 12.51 | 282,447 | 3,533,412 | 6,074,686 |
Oct 15 2018 | CORI | Corium International, Inc ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | 12.50 | 500,000 | 6,250,000 | 5,574,686 |
Oct 15 2018 | CORI | Corium International, Inc ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | 12.51 | 500,000 | 6,255,000 | 5,074,686 |
Oct 15 2018 | CORI | Corium International, Inc ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | 12.52 | 2,350,000 | 29,422,000 | 2,724,686 |
Oct 05 2018 | FOLD | AMICUS THERAPEUTICS INC | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 12.45 | 20,000 | 249,000 | 20,694,424 |
Oct 05 2018 | FOLD | AMICUS THERAPEUTICS INC | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 12.69 | 30,000 | 380,700 | 20,724,424 |
Sep 25 2018 | FOLD | AMICUS THERAPEUTICS INC | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 12.53 | 50,000 | 626,500 | 20,674,424 |
Sep 17 2018 | FOLD | AMICUS THERAPEUTICS INC | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 11.74 | 100,000 | 1,174,000 | 20,624,424 |
Sep 14 2018 | FOLD | AMICUS THERAPEUTICS INC | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 12.00 | 500,000 | 6,001,500 | 20,524,424 |
Aug 14 2018 | ZGNX | ZOGENIX, INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 52.00 | 100,000 | 5,200,000 | 4,070,357 |
Aug 01 2018 | VRCA | Verrica Pharmaceuticals I ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 0.00 | 1,130,679 | 0 | 1,130,679 |
Aug 01 2018 | VRCA | Verrica Pharmaceuticals I ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 0.00 | 1,279,733 | 0 | 2,410,412 |
Aug 01 2018 | VRCA | Verrica Pharmaceuticals I ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 15.00 | 1,000,000 | 15,000,000 | 3,410,412 |
Aug 01 2018 | VRCA | Verrica Pharmaceuticals I ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | 0.00 | 1,937,984 | 0 | 0 |
Aug 01 2018 | VRCA | Verrica Pharmaceuticals I ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | 0.00 | 2,193,463 | 0 | 0 |
Aug 01 2018 | VRCA | Verrica Pharmaceuticals I ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 0.00 | 1,130,679 | 0 | 1,130,679 |
Aug 01 2018 | VRCA | Verrica Pharmaceuticals I ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 0.00 | 1,279,733 | 0 | 2,410,412 |
Aug 01 2018 | VRCA | Verrica Pharmaceuticals I ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 15.00 | 1,000,000 | 15,000,000 | 3,410,412 |
Aug 01 2018 | VRCA | Verrica Pharmaceuticals I ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | 0.00 | 1,937,984 | 0 | 0 |
Aug 01 2018 | VRCA | Verrica Pharmaceuticals I ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | 0.00 | 2,193,463 | 0 | 0 |
Jul 27 2018 | SLDB | Solid Biosciences Inc. | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | 37.89 | 1,835 | 69,528 | 1,835 |
Jul 26 2018 | AGRX | AGILE THERAPEUTICS INC | PERCEPTIVE ADVISORS LLC | Sell | 0.30 | 298,628 | 89,439 | 3,231,372 | |
Jul 26 2018 | AGRX | AGILE THERAPEUTICS INC | PERCEPTIVE ADVISORS LLC | Sell | 0.30 | 298,628 | 89,439 | 3,231,372 | |
Jul 20 2018 | QTNT | Quotient Ltd | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 5.80 | 2,306,034 | 13,374,997 | 8,789,054 |
Jul 20 2018 | QTNT | Quotient Ltd | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | 5.80 | 2,306,034 | 13,374,997 | 0 |
Jul 20 2018 | CRNX | Crinetics Pharmaceuticals ... | PERCEPTIVE ADVISORS LLC | Director | Buy | 0.00 | 1,880,305 | 0 | 1,880,305 |
Jul 20 2018 | CRNX | Crinetics Pharmaceuticals ... | PERCEPTIVE ADVISORS LLC | Director | Buy | 17.00 | 400,000 | 6,800,000 | 2,280,305 |
Jul 20 2018 | CRNX | Crinetics Pharmaceuticals ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | 0.00 | 6,186,205 | 0 | 0 |
Jun 13 2018 | DOVA | Dova Pharmaceuticals, Inc ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 29.18 | 14,109 | 411,701 | 3,120,260 |
Jun 13 2018 | DOVA | Dova Pharmaceuticals, Inc ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 29.82 | 5,591 | 166,724 | 3,125,851 |
Jun 12 2018 | MGTX | MeiraGTx Holdings plc | PERCEPTIVE ADVISORS LLC | Director | Buy | 15.22 | 50,000 | 761,000 | 3,370,065 |
Jun 12 2018 | MGTX | MeiraGTx Holdings plc | PERCEPTIVE ADVISORS LLC | Director | Buy | 15.00 | 1,333,333 | 19,999,995 | 4,703,398 |
Jun 12 2018 | DOVA | Dova Pharmaceuticals, Inc ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 28.62 | 23,000 | 658,260 | 3,104,151 |
Jun 12 2018 | DOVA | Dova Pharmaceuticals, Inc ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 28.97 | 2,000 | 57,940 | 3,106,151 |
Jun 11 2018 | DOVA | Dova Pharmaceuticals, Inc ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 27.63 | 22,377 | 618,277 | 3,053,528 |
Jun 11 2018 | DOVA | Dova Pharmaceuticals, Inc ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 28.40 | 19,223 | 545,933 | 3,072,751 |
Jun 11 2018 | DOVA | Dova Pharmaceuticals, Inc ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 29.16 | 8,400 | 244,944 | 3,081,151 |
Jun 08 2018 | DOVA | Dova Pharmaceuticals, Inc ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 28.30 | 48,237 | 1,365,107 | 2,979,388 |
Jun 08 2018 | DOVA | Dova Pharmaceuticals, Inc ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 28.99 | 51,763 | 1,500,609 | 3,031,151 |
Jun 06 2018 | DOVA | Dova Pharmaceuticals, Inc ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 25.07 | 10,000 | 250,700 | 2,831,151 |
May 24 2018 | QTNT | Quotient Ltd | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 6.24 | 218,008 | 1,360,370 | 6,251,028 |
May 24 2018 | QTNT | Quotient Ltd | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 6.65 | 231,992 | 1,542,747 | 6,483,020 |
Mar 26 2018 | LJPC | LA JOLLA PHARMACEUTICAL C ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 29.50 | 700,000 | 20,650,000 | 4,313,611 |
Mar 07 2018 | FOLD | AMICUS THERAPEUTICS INC | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 13.56 | 335,827 | 4,553,814 | 18,424,424 |
Mar 06 2018 | FOLD | AMICUS THERAPEUTICS INC | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 13.90 | 100,000 | 1,389,500 | 18,088,597 |
Feb 21 2018 | MOTS | Motus GI Holdings, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | 5.00 | 180,055 | 900,275 | 180,055 |
Feb 20 2018 | LJPC | LA JOLLA PHARMACEUTICAL C ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 32.42 | 50,000 | 1,621,000 | 3,613,611 |
Feb 15 2018 | LJPC | LA JOLLA PHARMACEUTICAL C ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 32.75 | 75,000 | 2,456,250 | 3,463,611 |
Feb 15 2018 | LJPC | LA JOLLA PHARMACEUTICAL C ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 32.69 | 100,000 | 3,269,000 | 3,563,611 |
Jan 30 2018 | SLDB | Solid Biosciences Inc. | PERCEPTIVE ADVISORS LLC | Director | Buy | 16.00 | 1,000,000 | 16,000,000 | 3,907,222 |
Jan 30 2018 | SLDB | Solid Biosciences Inc. | PERCEPTIVE ADVISORS LLC | Director | Buy | 27.33 | 20,000 | 546,520 | 3,927,222 |
Jan 25 2018 | ALBO | ALBIREO PHARMA, INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 33.00 | 275,000 | 9,075,000 | 1,595,000 |
Jan 18 2018 | CORI | Corium International, Inc ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 11.83 | 50,350 | 595,641 | 5,897,483 |
Jan 18 2018 | CORI | Corium International, Inc ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 12.24 | 149,650 | 1,831,716 | 6,047,133 |
Jan 18 2018 | CORI | Corium International, Inc ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 12.80 | 310,000 | 3,968,000 | 6,357,133 |
Dec 19 2017 | GBT | Global Blood Therapeutics ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 38.00 | 175,000 | 6,650,000 | 4,889,066 |
Oct 30 2017 | VBIV | VBI Vaccines Inc/BC | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 3.05 | 3,100,000 | 9,455,000 | 9,345,725 |
Oct 03 2017 | ZGNX | ZOGENIX, INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 31.19 | 28,033 | 874,220 | 3,476,335 |
Oct 03 2017 | ZGNX | ZOGENIX, INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 31.90 | 102,199 | 3,260,240 | 3,578,534 |
Oct 03 2017 | ZGNX | ZOGENIX, INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 32.96 | 15,937 | 525,311 | 3,594,471 |
Oct 03 2017 | ZGNX | ZOGENIX, INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 33.86 | 8,260 | 279,665 | 3,602,731 |
Oct 03 2017 | ZGNX | ZOGENIX, INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 34.91 | 6,000 | 209,475 | 3,608,731 |
Oct 03 2017 | ZGNX | ZOGENIX, INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 36.26 | 3,800 | 137,805 | 3,612,531 |
Oct 03 2017 | ZGNX | ZOGENIX, INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 37.14 | 6,153 | 228,530 | 3,618,684 |
Oct 03 2017 | ZGNX | ZOGENIX, INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 38.56 | 8,112 | 312,791 | 3,626,796 |
Oct 03 2017 | ZGNX | ZOGENIX, INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 39.22 | 12,586 | 493,600 | 3,639,382 |
Oct 03 2017 | ZGNX | ZOGENIX, INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 40.14 | 8,920 | 358,081 | 3,648,302 |
Oct 03 2017 | ZGNX | ZOGENIX, INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 27.67 | 22,055 | 610,341 | 3,670,357 |
Oct 03 2017 | ZGNX | ZOGENIX, INC. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 37.50 | 300,000 | 11,250,000 | 3,970,357 |
Sep 25 2017 | VSAR | Versartis, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | 3.74 | 126,579 | 473,659 | 4,102,984 |
Sep 25 2017 | VSAR | Versartis, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | 3.56 | 353,421 | 1,258,143 | 3,749,563 |
Sep 25 2017 | VSAR | Versartis, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | 3.09 | 300,000 | 926,250 | 3,449,563 |
Sep 25 2017 | VSAR | Versartis, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | 3.03 | 250,000 | 757,250 | 3,199,563 |
Sep 25 2017 | VSAR | Versartis, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | 3.17 | 250,000 | 792,500 | 2,949,563 |
Sep 25 2017 | VSAR | Versartis, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | 3.27 | 500,000 | 1,633,250 | 2,449,563 |